EE631 Cost Minimization Analysis of the Switch to a New Immunization Schedule With a Hexavalent (DTAP-HBV-HIB-IPV) Vaccine in Algeria
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.870
https://www.valueinhealthjournal.com/article/S1098-3015(22)03074-1/fulltext
Title :
EE631 Cost Minimization Analysis of the Switch to a New Immunization Schedule With a Hexavalent (DTAP-HBV-HIB-IPV) Vaccine in Algeria
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03074-1&doi=10.1016/j.jval.2022.09.870
First page :
Section Title :
Open access? :
No
Section Order :
10415